RALLIS CHRIS A 4
4 · FENNEC PHARMACEUTICALS INC. · Filed Jul 7, 2025
Insider Transaction Report
Form 4
RALLIS CHRIS A
Director
Transactions
- Exercise/Conversion
Common Shares
2025-07-07$2.35/sh+2,127$4,998→ 55,911 total - Sale
Common Shares
2025-07-07$8.71/sh−1,119$9,746→ 54,792 total - Exercise/Conversion
Common Shares
2025-07-07$2.35/sh−2,127$4,998→ 178,406 totalExercise: $2.35From: 2015-08-03Exp: 2025-08-03→ Options (2,127 underlying)
Footnotes (3)
- [F1]Shares acquired through the exercise of an option pursuant to a 10b5-1 plan adopted on August 17, 2023.
- [F2]Shares sold to satisfy tax obligation on option exercise.
- [F3]Represents options exercised pursuant to a 10b5-1 plan adopted on August 17, 2023.